What is Curanex Pharmaceuticals Inc Common Stock's Market Cap?

Curanex Pharmaceuticals Inc Common Stock's Market Cap is $131.7M, based on as-reported figures from SEC (XBRL) filings.

What is Curanex Pharmaceuticals Inc Common Stock's Enterprise Value?

Curanex Pharmaceuticals Inc Common Stock's Enterprise Value is $128.8M, based on as-reported figures from SEC (XBRL) filings.

What is Curanex Pharmaceuticals Inc Common Stock's Net Income (TTM)?

Curanex Pharmaceuticals Inc Common Stock's Net Income (TTM) is -$10.5M, based on as-reported figures from SEC (XBRL) filings.

What is Curanex Pharmaceuticals Inc Common Stock's Diluted EPS (TTM)?

Curanex Pharmaceuticals Inc Common Stock's Diluted EPS (TTM) is -0.33, based on as-reported figures from SEC (XBRL) filings.

What is Curanex Pharmaceuticals Inc Common Stock's Net Debt?

Curanex Pharmaceuticals Inc Common Stock's Net Debt is -$2.9M, based on as-reported figures from SEC (XBRL) filings.

Curanex Pharmaceuticals Inc Common Stock (CURX) Financial Statements

Curanex Pharmaceuticals Inc Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01QB818P5

XNAS · usd

4.20▼ 0.84 (-16.67%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close5.04

Day's Range4.20 – 5.26

52-Week Range0.18 – 9.18

Volume40.0K

Avg Volume144.3K

Share Statistics

Shares Outstanding

Employees6

ExchangeXNAS

Listed2025-08-26

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Curanex Pharmaceuticals Inc Common Stock (CURX)

What is Curanex Pharmaceuticals Inc Common Stock's Market Cap?: Curanex Pharmaceuticals Inc Common Stock's Market Cap is $131.7M, based on as-reported figures from SEC (XBRL) filings.
What is Curanex Pharmaceuticals Inc Common Stock's Enterprise Value?: Curanex Pharmaceuticals Inc Common Stock's Enterprise Value is $128.8M, based on as-reported figures from SEC (XBRL) filings.
What is Curanex Pharmaceuticals Inc Common Stock's Net Income (TTM)?: Curanex Pharmaceuticals Inc Common Stock's Net Income (TTM) is -$10.5M, based on as-reported figures from SEC (XBRL) filings.
What is Curanex Pharmaceuticals Inc Common Stock's Diluted EPS (TTM)?: Curanex Pharmaceuticals Inc Common Stock's Diluted EPS (TTM) is -0.33, based on as-reported figures from SEC (XBRL) filings.
What is Curanex Pharmaceuticals Inc Common Stock's Net Debt?: Curanex Pharmaceuticals Inc Common Stock's Net Debt is -$2.9M, based on as-reported figures from SEC (XBRL) filings.